Mammalian erythrocytes have large amounts of catalase, an enzyme which catabolizes hydrogen peroxide (H202). Because catalase has a low affinity for H202, others have suggested that glutathione peroxidase clears most H202 within the erythrocyte and that catalase is of little import. We hypothesized that erythrocyte catalase might function to protect heterologous somatic cells against challenge by high levels of exogenous H202 (e.g., in areas of inflammation). We find that, whereas nucleated cells (L1210 murine leukemia) are readily killed by an enzymatically generated flux of superoxide (and, therefore, H202), the addition of human and murine erythrocytes blocks lethal damage to the target cells. Inhibition of erythrocyte superoxide dismutase, depletion of glutathione, and lysis of the erythrocytes do not diminish this protection. However, inhibition of erythrocyte catalase abrogates the protective effect and the addition of purified catalase (but not superoxide dismutase) restores it. Furthermore, erythrocytes derived from congenitally hypocatalasemic mice (in which other antioxidant systems are intact) do not protect L1210 cells. Our results raise the possibility that the erythrocyte may serve as protection against by-products of its own cargo, oxygen.
Introduction
Mammalian erythrocytes are endowed with extraordinarily high activities of catalase (E.C. 1. 1 1.1.6). Catalase decomposes hydrogen peroxide (H202) to water and oxygen either in a twostep catalatic reaction with H202 or in a peroxidatic reaction involving H202 and electron donors such as reduced pyridine nucleotides or ethanol (1) .
Despite the remarkably high activity of catalase in erythrocytes, the function of this enzyme is in question. Catalase has a much lower affinity for H202 than does glutathione peroxidase. Indeed, others have suggested that, under physiological conditions, practically all H202 encountered by erythrocytes is detoxified by glutathione peroxidase and that catalase has no role in the clearance of H202 (2) Assays. Erythrocyte GSH content was determined as described earlier (7). Catalase activity was assessed by spectrophotometric determination of the decomposition of H202 (1). SOD was measured as previously reported (8) .
Experimental procedure. Oxidant-induced damage to L1210 was assessed by the extent ofsuppression of[3H]thymidine incorporation. L1210 cells (105/ml) were incubated in RPMI 1640 with 10% fetal calf serum containing 0.1 Ci/ml [3H]thymidine. Activated oxygen was generated by the addition of hypoxanthine (3.6 mM final concentration) and xanthine oxidase (100 mU/ml). By calculation, this should generate -0.1 Mmol -°2 /min. The extent of oxidant-induced damage to the target L 1210 cells was estimated by the decrement in accumulation of acidinsoluble [3HJthymidine, a reflection of nucleic acid synthesis. The cell suspensions (total incubation volume = 1.0 ml) were precipitated by the direct addition of 100 ,ul of 100% trichloroacetic acid. The precipitate was collected and washed on Whatman GF/C glass filters (Whatman Laboratory Products, Inc., Clifton, NJ). The precipitate was resolubilized by addition of these filters to toluene/Liquifluor/ I0% Biosolve and radioactivity determined by liquid scintillation counting.
Results
Under these experimental conditions, untreated L12 10 cells accumulate [3Hjthymidine in a linear fashion over periods ofmore were lysed by freezing and thawing three times before addition to the L12 10 hypoxanthine/xanthine oxidase system. Such lysed erythrocytes are fully protective of the L1210 cells (Table I) . Second, erythrocyte GSH was completely reacted with I-chloro-2,4-dinitrobenzene. GSH-depleted cells are also fully effective in protecting L12 10 cells against hypoxanthine/xanthine oxidasegenerated oxidants (Fig. 2) . Third, inhibition of erythrocyte SOD by diethyldithiocarbamate (residual enzyme activity, <5% of initial) has little influence on the protective effects oferythrocytes. However, inhibition of erythrocyte catalase by preincubation with 3-amino-1 ,2-aminotriazole (residual activity, '-8% of initial) abrogates this protection (Fig. 2) . The fact that inhibition of catalase is the single maneuver which suppresses the protection of L12 10 cells by erythrocytes suggests that this enzyme is responsible for the majority of the effect. This conclusion is strengthened by two additional lines of experimental evidence. First, the addition of purified catalase, but not SOD, duplicates the protection afforded by erythrocytes (Fig. 2) . Second, normal mouse (C3H) erythrocytes have similar protective effects. However, erythrocytes derived from hypocatalasemic C3H mice (catalase activity < 5% of normal) are not protective (Table I) .
Discussion
The marked protective effects, by added erythrocytes, of L12 10 cells exposed to a flux of *°-and H202 derived therefrom are in accord with observations recently published by two other groups. Toth et al. (9) found that perfusion of isolated rat lungs with * 02-generating systems or H202 caused vascular leakage and edema. The inclusion oferythrocytes in this model prevented such oxidant-induced damage. Furthermore, van Asbeck et al.
(10) reported that prior insufflation of erythrocytes into the lungs of rats protected the animals against early death due to oxygen toxicity.
Neither of these groups adduced conclusive evidence as to the erythrocyte oxidant defense system(s) involved in such protection. In the present investigations, we have employed a more reductionistic experimental design which allowed us to dissect the erythrocyte oxidant defense mechanisms. It (2) . However, in some situations (such as acute inflammation), erythrocyte catalase activity may be important in moderating the extent of inflammation and the oxidant damage to cells which are "innocent bystanders." Indeed, hypocatalasemic Japanese have severe oral gangrene ( 11) which may be attributable, in part, to the lack of erythrocyte antioxidant capacity and unregulated spread of inflammation. Our results may help explain the very high catalase activity in mammalian erythrocytes and suggest a reason for the extreme rarity of congenital hypocatalasemia in human populations.
